Search

Author/Creator Redin, Esther

1. Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy. (28th February 2021)

Authors:
Llopiz, Diana; Ruiz, Marta; Silva, Leyre; Repáraz, David; Aparicio, Belén; Egea, Josune; Lasarte, Juan J.; Redin, Esther; Calvo, Alfonso; Angel, Matthew; Berzofsky, Jay A.; Stroncek, David; Sarobe, Pablo
Journal:
Cancer letters
Issue:
Volume 499(2021)
Page Start:
279
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation. Issue 3 (3rd March 2021)

Authors:
Redin, Esther; Garmendia, Irati; Lozano, Teresa; Serrano, Diego; Senent, Yaiza; Redrado, Miriam; Villalba, Maria; De Andrea, Carlos E; Exposito, Francisco; Ajona, Daniel; Ortiz-Espinosa, Sergio; Remirez, Ana; Bertolo, Cristina; Sainz, Cristina; Garcia-Pedrero, Juana; Pio, Ruben; Lasarte, Juan; Ag...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery. (1st July 2019)

Authors:
Exposito, Francisco; Villalba, Maria; Redrado, Miriam; de Aberasturi, Arrate L.; Cirauqui, Cristina; Redin, Esther; Guruceaga, Elizabeth; de Andrea, Carlos; Vicent, Silvestre; Ajona, Daniel; Montuenga, Luis M.; Pio, Ruben; Calvo, Alfonso
Journal:
Cancer letters
Issue:
Volume 453(2019)
Page Start:
21
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗